TScan Therapeutics
TCRX
#7880
Rank
NZ$0.36 B
Marketcap
$6.91
Share price
2.28%
Change (1 day)
0.08%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -$4.72

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.96. In 2022 the company made an earnings per share (EPS) of -$4.72 a decrease over its 2021 EPS that were of -$3.73.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.720.09%
2022-$4.7226.25%
2021-$3.7399.58%
2020-$1.87